Board Committees

Patrick F. Williams has more than 20 years of experience across medical device, consumer product goods and technology sectors. Appointed as Chief Financial Officer of STAAR Surgical Company in July 2020, Mr. Williams is responsible for optimizing the financial performance of STAAR and ensuring the scalability of various functions to support high growth expansion. From 2016 to 2019, he served as the Chief Financial Officer of Sientra, Inc. before transitioning to General Manager for its miraDry® business unit. From 2012 to 2016, Mr. Williams served as Chief Financial Officer of ZELTIQ Aesthetics, Inc., a publicly-traded medical device company that was acquired by Allergan. Previously, he served as Vice President in finance, strategy and investor relations roles from 2007 to 2012 at NuVasive, Inc., a San-Diego based medical device company servicing the spine sector. He has also held finance roles with Callaway Golf and Kyocera Wireless. Mr. Williams received an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from the University of California, San Diego.

Dr. Kukekov received his Ph.D. in Neuroscience from Columbia University, College of Physicians & Surgeons in New York City. The focus of his research was the molecular mechanisms underlying programmed cell death of neuronal cells exposed to various pro-apoptotic conditions i.e. hypoxia, cytotoxic drugs, amyloid-beta, etc. After his thesis defense and post-doctoral position at Columbia, he spent 15 years on Wall Street, where he held a number of healthcare investment banking positions. For over a decade, he was a founding partner at Highline Research Advisors, served as a Managing Director at Summer Street Research Partners and at Paramount BioCapital, and was a Vice President at Rodman and Renshaw.

Dr. Kukekov received his undergraduate degree from the University of Colorado at Boulder in molecular, cellular and developmental biology and is a recipient of multiple research scholarship awards and publications in peer reviewed articles in leading scientific journals.

Mr. Rosa serves on the board of directors of NeuroOne and is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University, and a BS in Commerce and Engineering from Drexel University.

Dr. Kukekov received his Ph.D. in Neuroscience from Columbia University, College of Physicians & Surgeons in New York City. The focus of his research was the molecular mechanisms underlying programmed cell death of neuronal cells exposed to various pro-apoptotic conditions i.e. hypoxia, cytotoxic drugs, amyloid-beta, etc. After his thesis defense and post-doctoral position at Columbia, he spent 15 years on Wall Street, where he held a number of healthcare investment banking positions. For over a decade, he was a founding partner at Highline Research Advisors, served as a Managing Director at Summer Street Research Partners and at Paramount BioCapital, and was a Vice President at Rodman and Renshaw.

Dr. Kukekov received his undergraduate degree from the University of Colorado at Boulder in molecular, cellular and developmental biology and is a recipient of multiple research scholarship awards and publications in peer reviewed articles in leading scientific journals.

Mr. Rosa serves on the board of directors of NeuroOne and is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University, and a BS in Commerce and Engineering from Drexel University.

Patrick F. Williams has more than 20 years of experience across medical device, consumer product goods and technology sectors. Appointed as Chief Financial Officer of STAAR Surgical Company in July 2020, Mr. Williams is responsible for optimizing the financial performance of STAAR and ensuring the scalability of various functions to support high growth expansion. From 2016 to 2019, he served as the Chief Financial Officer of Sientra, Inc. before transitioning to General Manager for its miraDry® business unit. From 2012 to 2016, Mr. Williams served as Chief Financial Officer of ZELTIQ Aesthetics, Inc., a publicly-traded medical device company that was acquired by Allergan. Previously, he served as Vice President in finance, strategy and investor relations roles from 2007 to 2012 at NuVasive, Inc., a San-Diego based medical device company servicing the spine sector. He has also held finance roles with Callaway Golf and Kyocera Wireless. Mr. Williams received an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from the University of California, San Diego.

Mr. Rosa serves on the board of directors of NeuroOne and is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University, and a BS in Commerce and Engineering from Drexel University.

Dr. Kukekov received his Ph.D. in Neuroscience from Columbia University, College of Physicians & Surgeons in New York City. The focus of his research was the molecular mechanisms underlying programmed cell death of neuronal cells exposed to various pro-apoptotic conditions i.e. hypoxia, cytotoxic drugs, amyloid-beta, etc. After his thesis defense and post-doctoral position at Columbia, he spent 15 years on Wall Street, where he held a number of healthcare investment banking positions. For over a decade, he was a founding partner at Highline Research Advisors, served as a Managing Director at Summer Street Research Partners and at Paramount BioCapital, and was a Vice President at Rodman and Renshaw.

Dr. Kukekov received his undergraduate degree from the University of Colorado at Boulder in molecular, cellular and developmental biology and is a recipient of multiple research scholarship awards and publications in peer reviewed articles in leading scientific journals.

Patrick F. Williams has more than 20 years of experience across medical device, consumer product goods and technology sectors. Appointed as Chief Financial Officer of STAAR Surgical Company in July 2020, Mr. Williams is responsible for optimizing the financial performance of STAAR and ensuring the scalability of various functions to support high growth expansion. From 2016 to 2019, he served as the Chief Financial Officer of Sientra, Inc. before transitioning to General Manager for its miraDry® business unit. From 2012 to 2016, Mr. Williams served as Chief Financial Officer of ZELTIQ Aesthetics, Inc., a publicly-traded medical device company that was acquired by Allergan. Previously, he served as Vice President in finance, strategy and investor relations roles from 2007 to 2012 at NuVasive, Inc., a San-Diego based medical device company servicing the spine sector. He has also held finance roles with Callaway Golf and Kyocera Wireless. Mr. Williams received an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from the University of California, San Diego.